Vespa velutina chromosome 21, iVesVel2.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU525143.1.\nAssembly name: iVesVel2.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/08/14. The original whole-genome shotgun project has the\naccession CAJVVP000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa velutina Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124956224, transcript variant X6
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC124956224, transcript variant X1
uncharacterized LOC124956224, transcript variant X4
uncharacterized LOC124956224, transcript variant X2
uncharacterized LOC124956224, transcript variant X5
uncharacterized LOC124956224, transcript variant X3
cytochrome P450 4c21-like, transcript variant X6
cytochrome P450 4c21-like, transcript variant X5
cytochrome P450 4c21-like, transcript variant X4
cytochrome P450 4c21-like, transcript variant X3
cytochrome P450 4c21-like, transcript variant X1
cytochrome P450 4c21-like, transcript variant X2
uncharacterized LOC124956188, transcript variant X8
uncharacterized LOC124956188, transcript variant X5
uncharacterized LOC124956188, transcript variant X6
uncharacterized LOC124956188, transcript variant X7
uncharacterized LOC124956188, transcript variant X2
uncharacterized LOC124956188, transcript variant X1
uncharacterized LOC124956188, transcript variant X3
uncharacterized LOC124956188, transcript variant X4
uncharacterized LOC124956191, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124956191, transcript variant X9
uncharacterized LOC124956191, transcript variant X6
uncharacterized LOC124956191, transcript variant X4
uncharacterized LOC124956191, transcript variant X5
uncharacterized LOC124956191, transcript variant X1
uncharacterized LOC124956191, transcript variant X7
uncharacterized LOC124956191, transcript variant X3
uncharacterized LOC124956191, transcript variant X2
uncharacterized LOC124956193, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124956193, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124956190, transcript variant X3
uncharacterized LOC124956190, transcript variant X4
uncharacterized LOC124956190, transcript variant X1
uncharacterized LOC124956190, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
uncharacterized LOC124956230, transcript variant X2
uncharacterized LOC124956230, transcript variant X1
uncharacterized LOC124956230, transcript variant X3
uncharacterized protein LOC124956230 isoform X1
uncharacterized protein LOC124956230 isoform X3
uncharacterized protein LOC124956230 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
40S ribosomal protein S10-like, transcript variant X1
40S ribosomal protein S10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124956340, transcript variant X1
uncharacterized LOC124956340, transcript variant X2
uncharacterized LOC124956340, transcript variant X4
uncharacterized LOC124956340, transcript variant X3
uncharacterized protein LOC124956340 isoform X2
uncharacterized protein LOC124956340 isoform X4
uncharacterized protein LOC124956340 isoform X1
uncharacterized protein LOC124956340 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124956370, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124956370, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124956370, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124956370, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC124956370 isoform X1
uncharacterized protein LOC124956370 isoform X2
serine/threonine-protein kinase N, transcript variant X2
serine/threonine-protein kinase N, transcript variant X4
serine/threonine-protein kinase N, transcript variant X1
serine/threonine-protein kinase N, transcript variant X3
serine/threonine-protein kinase N isoform X3
serine/threonine-protein kinase N isoform X4
serine/threonine-protein kinase N isoform X2
serine/threonine-protein kinase N isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
conserved oligomeric Golgi complex subunit 6, transcript variant X1
conserved oligomeric Golgi complex subunit 6, transcript variant X2
conserved oligomeric Golgi complex subunit 6 isoform X1
conserved oligomeric Golgi complex subunit 6 isoform X2
b(0,+)-type amino acid transporter 1-like
queuine tRNA-ribosyltransferase accessory subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
queuine tRNA-ribosyltransferase accessory subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ZZ-type zinc finger-containing protein 3
queuine tRNA-ribosyltransferase accessory subunit 2 isoform X2
queuine tRNA-ribosyltransferase accessory subunit 2 isoform X1
ankyrin repeat domain-containing protein SOWAHB, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ankyrin repeat domain-containing protein SOWAHB, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat domain-containing protein SOWAHB, transcript variant X4
ankyrin repeat domain-containing protein SOWAHB, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ankyrin repeat domain-containing protein SOWAHB, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ankyrin repeat domain-containing protein SOWAHC isoform X5
ankyrin repeat domain-containing protein SOWAHC isoform X3
ankyrin repeat domain-containing protein SOWAHB isoform X4
ankyrin repeat domain-containing protein SOWAHB isoform X1
ankyrin repeat domain-containing protein SOWAHB isoform X2
ankyrin repeat domain-containing protein SOWAHB, transcript variant X6
homeobox protein araucan, transcript variant X1
homeobox protein araucan, transcript variant X2
iroquois-class homeodomain protein IRX-6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
iroquois-class homeodomain protein IRX-6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
iroquois-class homeodomain protein IRX-6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
iroquois-class homeodomain protein IRX-6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
iroquois-class homeodomain protein IRX-6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X1
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X2
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X3
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X8
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X5
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X7
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X4
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X13
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X9
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X12
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X10
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X11
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X6
calponin homology domain-containing protein DDB_G0272472-like, transcript variant X14
uncharacterized protein LOC124956196 isoform X2
uncharacterized protein LOC124956196 isoform X1
uncharacterized protein LOC124956196 isoform X3
uncharacterized protein LOC124956196 isoform X5
uncharacterized protein LOC124956196 isoform X4
calponin homology domain-containing protein DDB_G0272472-like isoform X6
calponin homology domain-containing protein DDB_G0272472-like isoform X7
ATP-binding cassette sub-family F member 2, transcript variant X2
ATP-binding cassette sub-family F member 2, transcript variant X1
ATP-binding cassette sub-family F member 2
transmembrane protein 98-like, transcript variant X2
transmembrane protein 98-like, transcript variant X1
ubiquitin-conjugating enzyme E2 J2, transcript variant X2
ubiquitin-conjugating enzyme E2 J2, transcript variant X1
ubiquitin-conjugating enzyme E2 J2 isoform X1
ubiquitin-conjugating enzyme E2 J2 isoform X2
probable serine/threonine-protein kinase dyrk1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable serine/threonine-protein kinase dyrk1 isoform X2
probable serine/threonine-protein kinase dyrk1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable serine/threonine-protein kinase dyrk1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription factor SPT20 homolog isoform X1
Bardet-Biedl syndrome 7 protein homolog, transcript variant X4
Bardet-Biedl syndrome 7 protein homolog isoform X2
twist-related protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
twist-related protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
twist-related protein 2-like, transcript variant X1
twist-related protein 2-like, transcript variant X2
Bardet-Biedl syndrome 7 protein homolog, transcript variant X6
Bardet-Biedl syndrome 7 protein homolog isoform X4
uncharacterized LOC124956212, transcript variant X1
uncharacterized LOC124956212, transcript variant X2
uncharacterized LOC124956212, transcript variant X3
uncharacterized protein LOC124956212 isoform X1
uncharacterized protein LOC124956212 isoform X2
Bardet-Biedl syndrome 7 protein homolog, transcript variant X7
Bardet-Biedl syndrome 7 protein homolog, transcript variant X5
Bardet-Biedl syndrome 7 protein homolog, transcript variant X1
Bardet-Biedl syndrome 7 protein homolog, transcript variant X2
Bardet-Biedl syndrome 7 protein homolog, transcript variant X3
Bardet-Biedl syndrome 7 protein homolog isoform X1
Bardet-Biedl syndrome 7 protein homolog isoform X3
Bardet-Biedl syndrome 7 protein homolog isoform X5
zinc finger protein 45-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 45-like, transcript variant X1
zinc finger protein 45-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
trinucleotide repeat-containing gene 6C protein, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
trinucleotide repeat-containing gene 6C protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
trinucleotide repeat-containing gene 6C protein, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
trinucleotide repeat-containing gene 6C protein, transcript variant X1
trinucleotide repeat-containing gene 6C protein, transcript variant X4
trinucleotide repeat-containing gene 6C protein, transcript variant X6
trinucleotide repeat-containing gene 6C protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
trinucleotide repeat-containing gene 6C protein, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
trinucleotide repeat-containing gene 6C protein, transcript variant X5
trinucleotide repeat-containing gene 6C protein, transcript variant X9
trinucleotide repeat-containing gene 6C protein, transcript variant X8
trinucleotide repeat-containing gene 6C protein, transcript variant X2
trinucleotide repeat-containing gene 6C protein isoform X1
trinucleotide repeat-containing gene 6C protein isoform X2
trinucleotide repeat-containing gene 6C protein isoform X10
trinucleotide repeat-containing gene 6C protein isoform X3
trinucleotide repeat-containing gene 6C protein isoform X5
trinucleotide repeat-containing gene 6C protein isoform X6
trinucleotide repeat-containing gene 6C protein isoform X9
trinucleotide repeat-containing gene 6C protein isoform X4
trinucleotide repeat-containing gene 6C protein isoform X8
trinucleotide repeat-containing gene 6C protein isoform X7
trinucleotide repeat-containing gene 6C protein isoform X11
uncharacterized LOC124956327, transcript variant X2
uncharacterized LOC124956327, transcript variant X1
diacylglycerol O-acyltransferase 1, transcript variant X12
diacylglycerol O-acyltransferase 1, transcript variant X6
diacylglycerol O-acyltransferase 1, transcript variant X8
diacylglycerol O-acyltransferase 1, transcript variant X3
diacylglycerol O-acyltransferase 1, transcript variant X10
diacylglycerol O-acyltransferase 1, transcript variant X11
diacylglycerol O-acyltransferase 1, transcript variant X13
diacylglycerol O-acyltransferase 1, transcript variant X2
diacylglycerol O-acyltransferase 1, transcript variant X1
diacylglycerol O-acyltransferase 1, transcript variant X4
diacylglycerol O-acyltransferase 1, transcript variant X5
diacylglycerol O-acyltransferase 1, transcript variant X9
diacylglycerol O-acyltransferase 1, transcript variant X7
diacylglycerol O-acyltransferase 1 isoform X1
diacylglycerol O-acyltransferase 1 isoform X2
probable E3 ubiquitin-protein ligase bre1, transcript variant X2
probable E3 ubiquitin-protein ligase bre1, transcript variant X1
probable E3 ubiquitin-protein ligase bre1 isoform X2
ranBP-type and C3HC4-type zinc finger-containing protein 1-like, transcript variant X1
ranBP-type and C3HC4-type zinc finger-containing protein 1-like, transcript variant X2
uncharacterized protein LOC124956203 isoform X1
ranBP-type and C3HC4-type zinc finger-containing protein 1-like isoform X2
39S ribosomal protein L10, mitochondrial
UBX domain-containing protein 4-like, transcript variant X1
UBX domain-containing protein 4-like, transcript variant X2
barH-like 1 homeobox protein, transcript variant X1
barH-like 1 homeobox protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
homeotic protein distal-less, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
homeotic protein distal-less, transcript variant X6
homeotic protein distal-less, transcript variant X2
homeotic protein distal-less, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
homeotic protein distal-less, transcript variant X3
homeotic protein distal-less, transcript variant X4
homeotic protein distal-less, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate decarboxylase, transcript variant X1
glutamate decarboxylase, transcript variant X2
fumarylacetoacetase, transcript variant X2
fumarylacetoacetase, transcript variant X1
fas apoptotic inhibitory molecule 1, transcript variant X2
fas apoptotic inhibitory molecule 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fas apoptotic inhibitory molecule 1 isoform X1
fas apoptotic inhibitory molecule 1 isoform X2
coiled-coil domain-containing protein 113-like
angiotensin-converting enzyme-like, transcript variant X5
angiotensin-converting enzyme-like, transcript variant X4
angiotensin-converting enzyme-like isoform X4
angiotensin-converting enzyme-like, transcript variant X3
angiotensin-converting enzyme-like isoform X5
angiotensin-converting enzyme-like isoform X3
angiotensin-converting enzyme-like, transcript variant X1
angiotensin-converting enzyme-like, transcript variant X2
angiotensin-converting enzyme-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
angiotensin-converting enzyme-like, transcript variant X7
angiotensin-converting enzyme-like isoform X1
angiotensin-converting enzyme-like isoform X2
LIM domain-containing protein jub, transcript variant X3
LIM domain-containing protein jub, transcript variant X1
LIM domain-containing protein jub, transcript variant X2
LIM domain-containing protein jub isoform X2
LIM domain-containing protein jub isoform X1
uncharacterized LOC124956387, transcript variant X2
uncharacterized LOC124956387, transcript variant X1
probable serine/threonine-protein kinase tsuA, transcript variant X1
probable serine/threonine-protein kinase tsuA, transcript variant X2
probable serine/threonine-protein kinase tsuA
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X2
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X3
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X4
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X7
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X8
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X1
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X5
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X12
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X13
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X15
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X14
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X11
voltage-dependent L-type calcium channel subunit beta-3 isoform X7
voltage-dependent L-type calcium channel subunit beta-1 isoform X8
voltage-dependent L-type calcium channel subunit beta-1 isoform X5
voltage-dependent L-type calcium channel subunit beta-1 isoform X2
voltage-dependent L-type calcium channel subunit beta-3 isoform X3
voltage-dependent L-type calcium channel subunit beta-1 isoform X4
voltage-dependent L-type calcium channel subunit beta-1 isoform X1
voltage-dependent L-type calcium channel subunit beta-2 isoform X12
voltage-dependent L-type calcium channel subunit beta-2 isoform X14
voltage-dependent L-type calcium channel subunit beta-2 isoform X13
voltage-dependent L-type calcium channel subunit beta-2 isoform X11
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X10
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X9
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X6
voltage-dependent L-type calcium channel subunit beta-2 isoform X9
voltage-dependent L-type calcium channel subunit beta-1 isoform X6
voltage-dependent L-type calcium channel subunit beta-2 isoform X10
uncharacterized LOC124956391, transcript variant X1
uncharacterized LOC124956391, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X2
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X5
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X4
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X1
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X3
UDP-N-acetylhexosamine pyrophosphorylase
uncharacterized LOC124956339, transcript variant X1
uncharacterized LOC124956339, transcript variant X2
ADP-ribosylation factor 6, transcript variant X5
ADP-ribosylation factor 6, transcript variant X4
ADP-ribosylation factor 6, transcript variant X1
ADP-ribosylation factor 6, transcript variant X3
ADP-ribosylation factor 6, transcript variant X2
ADP-ribosylation factor 6, transcript variant X7
ADP-ribosylation factor 6, transcript variant X6
NF-kappa-B-repressing factor, transcript variant X2
NF-kappa-B-repressing factor, transcript variant X1
NF-kappa-B-repressing factor, transcript variant X4
NF-kappa-B-repressing factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124956338, transcript variant X3
uncharacterized LOC124956338, transcript variant X2
uncharacterized LOC124956338, transcript variant X1
microtubule-actin cross-linking factor 1, transcript variant X22
microtubule-actin cross-linking factor 1, transcript variant X27
microtubule-actin cross-linking factor 1, transcript variant X17
microtubule-actin cross-linking factor 1, transcript variant X33
microtubule-actin cross-linking factor 1, transcript variant X31
microtubule-actin cross-linking factor 1, transcript variant X25
microtubule-actin cross-linking factor 1, transcript variant X32
microtubule-actin cross-linking factor 1, transcript variant X49
microtubule-actin cross-linking factor 1, transcript variant X47
microtubule-actin cross-linking factor 1, transcript variant X48
microtubule-actin cross-linking factor 1, transcript variant X46
microtubule-actin cross-linking factor 1, transcript variant X18
microtubule-actin cross-linking factor 1, transcript variant X13
microtubule-actin cross-linking factor 1, transcript variant X14
microtubule-actin cross-linking factor 1, transcript variant X12
microtubule-actin cross-linking factor 1, transcript variant X45
microtubule-actin cross-linking factor 1, transcript variant X41
microtubule-actin cross-linking factor 1, transcript variant X30
microtubule-actin cross-linking factor 1, transcript variant X26
microtubule-actin cross-linking factor 1, transcript variant X16
microtubule-actin cross-linking factor 1, transcript variant X24
microtubule-actin cross-linking factor 1, transcript variant X43
microtubule-actin cross-linking factor 1, transcript variant X36
microtubule-actin cross-linking factor 1, transcript variant X35
microtubule-actin cross-linking factor 1, transcript variant X15
microtubule-actin cross-linking factor 1, transcript variant X23
microtubule-actin cross-linking factor 1, transcript variant X29
microtubule-actin cross-linking factor 1, transcript variant X21
microtubule-actin cross-linking factor 1, transcript variant X7
microtubule-actin cross-linking factor 1, transcript variant X19
microtubule-actin cross-linking factor 1, transcript variant X11
microtubule-actin cross-linking factor 1, transcript variant X3
microtubule-actin cross-linking factor 1, transcript variant X6
microtubule-actin cross-linking factor 1, transcript variant X4
microtubule-actin cross-linking factor 1, transcript variant X10
microtubule-actin cross-linking factor 1, transcript variant X2
microtubule-actin cross-linking factor 1, transcript variant X5
microtubule-actin cross-linking factor 1, transcript variant X9
microtubule-actin cross-linking factor 1, transcript variant X28
microtubule-actin cross-linking factor 1, transcript variant X20
microtubule-actin cross-linking factor 1, transcript variant X1
microtubule-actin cross-linking factor 1, transcript variant X8
microtubule-actin cross-linking factor 1, transcript variant X40
microtubule-actin cross-linking factor 1, transcript variant X42
microtubule-actin cross-linking factor 1, transcript variant X37
microtubule-actin cross-linking factor 1, transcript variant X38
microtubule-actin cross-linking factor 1, transcript variant X34
microtubule-actin cross-linking factor 1, transcript variant X44
microtubule-actin cross-linking factor 1, transcript variant X50
microtubule-actin cross-linking factor 1, transcript variant X39
microtubule-actin cross-linking factor 1 isoform X30
microtubule-actin cross-linking factor 1 isoform X28
microtubule-actin cross-linking factor 1 isoform X22
microtubule-actin cross-linking factor 1 isoform X19
microtubule-actin cross-linking factor 1 isoform X29
microtubule-actin cross-linking factor 1 isoform X24
microtubule-actin cross-linking factor 1 isoform X15
microtubule-actin cross-linking factor 1 isoform X27
microtubule-actin cross-linking factor 1 isoform X23
microtubule-actin cross-linking factor 1 isoform X14
microtubule-actin cross-linking factor 1 isoform X21
microtubule-actin cross-linking factor 1 isoform X37
microtubule-actin cross-linking factor 1 isoform X12
microtubule-actin cross-linking factor 1 isoform X16
microtubule-actin cross-linking factor 1 isoform X11
microtubule-actin cross-linking factor 1 isoform X3
microtubule-actin cross-linking factor 1 isoform X6
microtubule-actin cross-linking factor 1 isoform X4
microtubule-actin cross-linking factor 1 isoform X10
microtubule-actin cross-linking factor 1 isoform X2
microtubule-actin cross-linking factor 1 isoform X20
microtubule-actin cross-linking factor 1 isoform X5
microtubule-actin cross-linking factor 1 isoform X13
microtubule-actin cross-linking factor 1 isoform X8
microtubule-actin cross-linking factor 1 isoform X26
microtubule-actin cross-linking factor 1 isoform X18
microtubule-actin cross-linking factor 1 isoform X9
microtubule-actin cross-linking factor 1 isoform X25
microtubule-actin cross-linking factor 1 isoform X17
microtubule-actin cross-linking factor 1 isoform X7
microtubule-actin cross-linking factor 1 isoform X1
microtubule-actin cross-linking factor 1 isoform X32
microtubule-actin cross-linking factor 1 isoform X44
microtubule-actin cross-linking factor 1 isoform X38
microtubule-actin cross-linking factor 1 isoform X31
microtubule-actin cross-linking factor 1 isoform X33
protein Cep89 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein Cep89 homolog, transcript variant X1
sodium-dependent neutral amino acid transporter B(0)AT3, transcript variant X3
sodium-dependent neutral amino acid transporter B(0)AT3, transcript variant X2
sodium-dependent neutral amino acid transporter B(0)AT3, transcript variant X1
sodium-dependent neutral amino acid transporter B(0)AT3 isoform X1
sodium-dependent neutral amino acid transporter B(0)AT3 isoform X2
dihydroceramide fatty acyl 2-hydroxylase FAH2
NF-kappa-B inhibitor-interacting Ras-like protein, transcript variant X2
NF-kappa-B inhibitor-interacting Ras-like protein, transcript variant X1
NF-kappa-B inhibitor-interacting Ras-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124956228, transcript variant X4
uncharacterized LOC124956228, transcript variant X3
uncharacterized LOC124956228, transcript variant X5
uncharacterized LOC124956228, transcript variant X6
uncharacterized LOC124956228, transcript variant X7
uncharacterized LOC124956228, transcript variant X1
uncharacterized LOC124956228, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
splicing factor U2af 38 kDa subunit-like
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X4
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X5
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X3
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X1
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X2
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X8
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X7
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X6
medium-chain acyl-CoA ligase ACSF2, mitochondrial
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A isoform X1
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A isoform X2
short transient receptor potential channel 3-like, transcript variant X2
short transient receptor potential channel 3-like, transcript variant X1
short transient receptor potential channel 3-like
transient-receptor-potential-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein LZIC-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein LZIC-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger MYND domain-containing protein 11, transcript variant X2
zinc finger MYND domain-containing protein 11, transcript variant X1
zinc finger MYND domain-containing protein 11 isoform X2
zinc finger MYND domain-containing protein 11 isoform X1
60S ribosome subunit biogenesis protein NIP7 homolog
tyrosine-protein phosphatase corkscrew, transcript variant X1
tyrosine-protein phosphatase corkscrew, transcript variant X2
DNA polymerase delta catalytic subunit, transcript variant X1
DNA polymerase delta catalytic subunit, transcript variant X3
tyrosine-protein phosphatase corkscrew isoform X1
tyrosine-protein phosphatase corkscrew isoform X2
DNA polymerase delta catalytic subunit, transcript variant X2
DNA polymerase delta catalytic subunit isoform X1
DNA polymerase delta catalytic subunit isoform X2
DNA polymerase delta catalytic subunit, transcript variant X4
DNA polymerase delta catalytic subunit isoform X3
DNA polymerase delta catalytic subunit, transcript variant X5
DNA polymerase delta catalytic subunit isoform X4
ADP-ribosylation factor-like protein 1, transcript variant X3
ADP-ribosylation factor-like protein 1, transcript variant X2
ADP-ribosylation factor-like protein 1, transcript variant X1
ADP-ribosylation factor-like protein 1 isoform X1
ADP-ribosylation factor-like protein 1 isoform X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X4
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X5
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X4
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X1
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X3
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X1
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X3
t-SNARE domain-containing protein 1, transcript variant X2
t-SNARE domain-containing protein 1, transcript variant X1
eukaryotic translation initiation factor 4 gamma 2, transcript variant X2
eukaryotic translation initiation factor 4 gamma 2, transcript variant X5
eukaryotic translation initiation factor 4 gamma 2, transcript variant X1
eukaryotic translation initiation factor 4 gamma 2, transcript variant X4
eukaryotic translation initiation factor 4 gamma 2, transcript variant X3
eukaryotic translation initiation factor 4 gamma 2, transcript variant X6
eukaryotic translation initiation factor 4 gamma 2 isoform X1
eukaryotic translation initiation factor 4 gamma 2 isoform X2
transcription initiation factor IIB, transcript variant X1
transcription initiation factor IIB, transcript variant X2
protein shisa-4-like, transcript variant X2
protein shisa-4-like, transcript variant X1
protein shisa-4-like, transcript variant X3
uncharacterized protein LOC124956324 isoform X1
coatomer subunit gamma, transcript variant X1
coatomer subunit gamma, transcript variant X2
uncharacterized LOC124956404, transcript variant X3
uncharacterized LOC124956404, transcript variant X2
uncharacterized LOC124956404, transcript variant X1
methionine aminopeptidase 2, transcript variant X1
methionine aminopeptidase 2, transcript variant X2
dihydrolipoyl dehydrogenase, mitochondrial, transcript variant X1
dihydrolipoyl dehydrogenase, mitochondrial, transcript variant X2
dihydrolipoyl dehydrogenase, mitochondrial isoform X1
dihydrolipoyl dehydrogenase, mitochondrial isoform X2
dedicator of cytokinesis protein 3, transcript variant X1
dedicator of cytokinesis protein 3, transcript variant X2
dedicator of cytokinesis protein 3 isoform X1
dedicator of cytokinesis protein 3 isoform X2
protocadherin-like wing polarity protein stan, transcript variant X1
protocadherin-like wing polarity protein stan, transcript variant X2
protocadherin-like wing polarity protein stan isoform X2
protocadherin-like wing polarity protein stan isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
cilia- and flagella-associated protein 69-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia- and flagella-associated protein 69-like, transcript variant X2
cilia- and flagella-associated protein 69-like isoform X1
cilia- and flagella-associated protein 69-like isoform X2
plexin domain-containing protein 2, transcript variant X2
plexin domain-containing protein 2, transcript variant X1
plexin domain-containing protein 2 isoform X1
plexin domain-containing protein 2 isoform X2
uncharacterized LOC124956256, transcript variant X5
uncharacterized LOC124956256, transcript variant X2
uncharacterized LOC124956256, transcript variant X7
uncharacterized LOC124956256, transcript variant X6
uncharacterized LOC124956256, transcript variant X4
uncharacterized LOC124956256, transcript variant X3
uncharacterized LOC124956256, transcript variant X1
39S ribosomal protein L47, mitochondrial
pleckstrin homology domain-containing family M member 2, transcript variant X6
pleckstrin homology domain-containing family M member 2, transcript variant X4
pleckstrin homology domain-containing family M member 2, transcript variant X1
pleckstrin homology domain-containing family M member 2, transcript variant X5
pleckstrin homology domain-containing family M member 2, transcript variant X2
pleckstrin homology domain-containing family M member 2, transcript variant X3
pleckstrin homology domain-containing family M member 2 isoform X4
pleckstrin homology domain-containing family M member 2 isoform X1
pleckstrin homology domain-containing family M member 2 isoform X3
pleckstrin homology domain-containing family M member 2 isoform X2
uncharacterized protein LOC124956234 isoform X5
uncharacterized protein LOC124956234 isoform X6
uncharacterized LOC124956257, transcript variant X2
uncharacterized LOC124956257, transcript variant X1
cardioacceleratory peptide receptor-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X1
cardioacceleratory peptide receptor-like, transcript variant X5
cardioacceleratory peptide receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cardioacceleratory peptide receptor-like isoform X1
cardioacceleratory peptide receptor-like isoform X3
cardioacceleratory peptide receptor-like isoform X2
uncharacterized LOC124956248, transcript variant X2
uncharacterized LOC124956248, transcript variant X3
uncharacterized LOC124956248, transcript variant X1
guanine nucleotide-binding protein-like 3 homolog
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X2
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X1
probable serine/threonine-protein kinase DDB_G0282963
39S ribosomal protein L55, mitochondrial
cystinosin homolog, transcript variant X2
cystinosin homolog, transcript variant X1
cystinosin homolog, transcript variant X4
cystinosin homolog, transcript variant X3
prion-like-(Q/N-rich) domain-bearing protein 25
rh5-interacting protein-like, transcript variant X1
rh5-interacting protein-like, transcript variant X2
39S ribosomal protein L51, mitochondrial
dipeptidyl peptidase 9, transcript variant X5
dipeptidyl peptidase 9, transcript variant X4
dipeptidyl peptidase 9, transcript variant X2
dipeptidyl peptidase 9, transcript variant X1
dipeptidyl peptidase 9, transcript variant X3
protein phosphatase 1 regulatory subunit 21
iron-sulfur cluster assembly 2 homolog, mitochondrial
transmembrane emp24 domain-containing protein bai
mitochondrial potassium channel-like, transcript variant X2
mitochondrial potassium channel-like, transcript variant X1
uncharacterized protein LOC124956306 isoform X2
mitochondrial potassium channel-like isoform X1
GDP-mannose 4,6 dehydratase, transcript variant X2
GDP-mannose 4,6 dehydratase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized PE-PGRS family protein PE_PGRS3-like
uncharacterized LOC124956300, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124956300, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
methyl farnesoate epoxidase-like, transcript variant X1
methyl farnesoate epoxidase-like, transcript variant X2
methyl farnesoate epoxidase-like isoform X1
methyl farnesoate epoxidase-like isoform X2
probable cytochrome P450 305a1, transcript variant X3
probable cytochrome P450 305a1, transcript variant X2
probable cytochrome P450 305a1, transcript variant X1
probable cytochrome P450 305a1, transcript variant X4
probable cytochrome P450 305a1 isoform X2
probable cytochrome P450 305a1 isoform X1
small subunit processome component 20 homolog, transcript variant X1
small subunit processome component 20 homolog, transcript variant X2
small subunit processome component 20 homolog isoform X1
small subunit processome component 20 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
odorant receptor 4-like, transcript variant X4
odorant receptor 4-like, transcript variant X2
odorant receptor 4-like, transcript variant X1
odorant receptor 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC124956302 isoform X3
neutral and basic amino acid transport protein rBAT-like isoform X1
neutral and basic amino acid transport protein rBAT-like isoform X2
DNA-directed RNA polymerase I subunit RPA1
coiled-coil and C2 domain-containing protein 1-like, transcript variant X1
coiled-coil and C2 domain-containing protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
coiled-coil and C2 domain-containing protein 1-like, transcript variant X3
coiled-coil and C2 domain-containing protein 1-like, transcript variant X2
coiled-coil and C2 domain-containing protein 1-like, transcript variant X6
coiled-coil and C2 domain-containing protein 1-like isoform X1
coiled-coil and C2 domain-containing protein 1-like isoform X3
coiled-coil and C2 domain-containing protein 1-like isoform X2
coiled-coil and C2 domain-containing protein 1-like isoform X6
coiled-coil and C2 domain-containing protein 1-like isoform X4
coiled-coil and C2 domain-containing protein 1-like, transcript variant X5
coiled-coil and C2 domain-containing protein 1-like isoform X5
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X1
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X9
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X2
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X4
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X6
histone-lysine N-methyltransferase 2D-like isoform X1
histone-lysine N-methyltransferase 2D-like isoform X2
putative mediator of RNA polymerase II transcription subunit 12 isoform X4
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X5
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X3
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X7
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X8
histone-lysine N-methyltransferase 2D-like isoform X3
putative mediator of RNA polymerase II transcription subunit 12 isoform X5
putative mediator of RNA polymerase II transcription subunit 12 isoform X6
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X10
PAX-interacting protein 1-like isoform X7
sodium channel protein Nach-like, transcript variant X1
sodium channel protein Nach-like, transcript variant X3
sodium channel protein Nach-like, transcript variant X2
sodium channel protein Nach-like isoform X1
sodium channel protein Nach-like isoform X2
sodium channel protein Nach-like isoform X3
eyes absent homolog 4, transcript variant X7
eyes absent homolog 4, transcript variant X8
eyes absent homolog 4, transcript variant X6
eyes absent homolog 4, transcript variant X5
eyes absent homolog 4, transcript variant X4
eyes absent homolog 4, transcript variant X3
eyes absent homolog 4, transcript variant X2
eyes absent homolog 4, transcript variant X1
nuclear transcription factor Y subunit gamma-like, transcript variant X3
nuclear transcription factor Y subunit gamma-like, transcript variant X2
nuclear transcription factor Y subunit gamma-like, transcript variant X1
nuclear transcription factor Y subunit gamma-like isoform X2
nuclear transcription factor Y subunit gamma-like isoform X1
intraflagellar transport protein 52 homolog
uncharacterized LOC124956361, transcript variant X2
uncharacterized LOC124956361, transcript variant X1
uncharacterized protein LOC124956361 isoform X2
uncharacterized protein LOC124956361 isoform X1
vesicular glutamate transporter 1, transcript variant X3
vesicular glutamate transporter 1, transcript variant X1
vesicular glutamate transporter 1, transcript variant X2
pancreatic lipase-related protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pancreatic lipase-related protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pancreatic lipase-related protein 2 isoform X1
pancreatic lipase-related protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns